EXICURE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
EXICURE, INC. (XCUR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-03-18
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.00K shares, a 99.14% decline from fiscal 2022.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 232.03K shares, a 94.76% decline from fiscal 2021.
- EXICURE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 4.43M shares, a 60.70% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-18 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-18 | 0.00 shares 10-K · filed 2025-03-18 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 0.00 shares 10-Q · filed 2024-11-14 | -8.00K shares derived: sum of 4 quarters · filed 2025-03-18 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 0.00 shares 10-Q · filed 2024-08-13 | -8.00K shares derived: sum of 3 quarters · filed 2025-03-18 | -8.00K shares derived: sum of 4 quarters · filed 2025-03-18 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-06-17 | -8.00K shares derived: sum of 2 quarters · filed 2025-03-18 | -8.00K shares derived: sum of 3 quarters · filed 2025-03-18 | -8.00K shares derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-12-31 | -8.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -8.00K shares derived: sum of 2 quarters · filed 2025-03-18 | -8.00K shares derived: sum of 3 quarters · filed 2025-03-18 | 2.00K shares 10-K · filed 2025-03-18 | 10.00K shares 10-K · filed 2024-06-06 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | 0.00 shares derived: sum of 2 quarters · filed 2024-06-06 | 10.00K shares 10-Q · filed 2024-05-16 | 10.00K shares derived: sum of 4 quarters · filed 2024-06-06 | |
| 2023-06-30 | 0.00 shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | 10.00K shares 10-Q/A · filed 2024-06-06 | 10.00K shares derived: sum of 3 quarters · filed 2024-06-06 | 10.00K shares derived: sum of 4 quarters · filed 2024-06-06 | |
| 2023-03-31 | 10.00K shares 10-Q/A · filed 2024-06-06 | 10.00K shares derived: sum of 2 quarters · filed 2024-06-06 | 10.00K shares derived: sum of 3 quarters · filed 2024-06-06 | 242.03K shares derived: sum of 4 quarters · filed 2024-06-06 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | 0.00 shares derived: sum of 2 quarters · filed 2024-06-06 | 232.03K shares derived: sum of 3 quarters · filed 2024-06-06 | 232.03K shares 10-K · filed 2024-06-06 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 232.03K shares derived: sum of 2 quarters · filed 2022-11-14 | 232.03K shares 10-Q · filed 2022-11-14 | 232.03K shares derived: sum of 4 quarters · filed 2024-06-06 | |
| 2022-06-30 | 232.03K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-08-15 | 232.03K shares 10-Q · filed 2022-08-15 | 232.03K shares derived: sum of 3 quarters · filed 2024-06-06 | 389.53K shares derived: sum of 4 quarters · filed 2024-06-06 | |
| 2022-03-31 | 0.00 shares 10-Q/A · filed 2024-06-06 | 0.00 shares derived: sum of 2 quarters · filed 2024-06-06 | 157.50K shares derived: sum of 3 quarters · filed 2024-06-06 | 3.82M shares derived: sum of 4 quarters · filed 2024-06-06 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | 157.50K shares derived: sum of 2 quarters · filed 2022-03-25 | 3.82M shares derived: sum of 3 quarters · filed 2022-03-25 | 4.43M shares 10-K · filed 2022-03-25 | |
| 2021-09-30 | 157.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | 3.82M shares derived: sum of 2 quarters · filed 2021-11-19 | 4.43M shares 10-Q · filed 2021-11-19 | 4.55M shares derived: sum of 4 quarters · filed 2021-11-19 | |
| 2021-06-30 | 3.67M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 4.27M shares 10-Q · filed 2021-08-12 | 4.40M shares derived: sum of 3 quarters · filed 2021-08-12 | 4.95M shares derived: sum of 4 quarters · filed 2021-08-12 | |
| 2021-03-31 | 603.39K shares 10-Q · filed 2021-05-12 | 728.39K shares derived: sum of 2 quarters · filed 2021-05-12 | 1.28M shares derived: sum of 3 quarters · filed 2021-05-12 | 2.15M shares derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-12-31 | 125.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 680.00K shares derived: sum of 2 quarters · filed 2021-03-11 | 1.54M shares derived: sum of 3 quarters · filed 2021-03-11 | 2.76M shares 10-K · filed 2021-03-11 | |
| 2020-09-30 | 555.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 1.42M shares derived: sum of 2 quarters · filed 2020-11-12 | 2.63M shares 10-Q · filed 2020-11-12 | 3.26M shares derived: sum of 4 quarters · filed 2020-11-12 | |
| 2020-06-30 | 863.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | 2.08M shares 10-Q · filed 2020-08-12 | 2.70M shares derived: sum of 3 quarters · filed 2020-08-12 | 2.89M shares derived: sum of 4 quarters · filed 2020-08-12 | |
| 2020-03-31 | 1.21M shares 10-Q · filed 2020-05-14 | 1.84M shares derived: sum of 2 quarters · filed 2020-05-14 | 2.02M shares derived: sum of 3 quarters · filed 2020-05-14 | 2.16M shares derived: sum of 4 quarters · filed 2020-05-14 | |
| 2019-12-31 | 627.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 813.04K shares derived: sum of 2 quarters · filed 2020-03-10 | 946.51K shares derived: sum of 3 quarters · filed 2020-03-10 | 1.24M shares 10-K · filed 2020-03-10 | |
| 2019-09-30 | 186.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 319.51K shares derived: sum of 2 quarters · filed 2019-11-07 | 617.01K shares 10-Q · filed 2019-11-07 | 617.01K shares derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-06-30 | 133.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 430.96K shares 10-Q · filed 2019-08-08 | 430.96K shares derived: sum of 3 quarters · filed 2019-09-23 | 568.47K shares derived: sum of 4 quarters · filed 2019-09-23 | |
| 2019-03-31 | 297.50K shares 10-Q · filed 2019-05-08 | 297.50K shares derived: sum of 2 quarters · filed 2019-09-23 | 435.00K shares derived: sum of 3 quarters · filed 2019-09-23 | 900.97K shares derived: sum of 4 quarters · filed 2019-09-23 | |
| 2018-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | 137.50K shares derived: sum of 2 quarters · filed 2019-09-23 | 603.47K shares derived: sum of 3 quarters · filed 2019-09-23 | 1.28M shares 10-K/A · filed 2019-09-23 | |
| 2018-09-30 | 137.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 603.47K shares derived: sum of 2 quarters · filed 2018-11-06 | 1.28M shares 10-Q · filed 2018-11-06 | 1.28M shares derived: sum of 4 quarters · filed 2018-11-06 | |
| 2018-06-30 | 465.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | 1.14M shares 10-Q · filed 2018-08-06 | 1.14M shares derived: sum of 3 quarters · filed 2018-08-06 | ||
| 2018-03-31 | 674.28K shares 10-Q · filed 2018-05-15 | 674.28K shares derived: sum of 2 quarters · filed 2018-05-15 | |||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | 657.84K shares 10-K · filed 2018-03-09 | |||
| 2017-09-30 | 657.84K shares 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |